Search clinical trials for: AGSPT201 Tab contains S-pantoprazole

Total 145 results

Ahn-Gook Pharmaceuticals Co.,Ltd

Completed

Efficacy Study of AGSPT201 Tablet to Treat Gastroesophageal Reflux Disease (AGSPT)

Gastroesophageal Reflux Disease

Korea, Republic of
Ahn-Gook Pharmaceuticals Co.,Ltd

Unknown

Investigate a Pharmacodynamics Between S-pantoprazole 10, 20, 40mg and Pantoprazole 20, 40mg in Healthy Male Subjects (AGSPT_PD)

Healthy Male Subjects
Ahn-Gook Pharmaceuticals Co.,Ltd

Unknown

S-pantoprazole 10mg Phase III Clinical Study

Non Erosive Reflux Disease

Korea, Republic of
Taiho Pharmaceutical Co., Ltd.

Completed

A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

Japan
S-There Technologies SL
Biocruces Bizkaia Health Research Institute; Hospital de Cruces

Unknown

Clinical Validation Through Analytical Study With Urine Samples to Compare the Effectiveness and Security of an Intelligent Device (STSD-2019-001)

Heart Failure | Renal Insufficiency, Chronic | Urinary Tract Infections | Diabete Mellitus | Hematuria | Diabetes; Nephropathy (Manifestation)

Spain
Zhejiang Cancer Hospital

Recruiting

Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Locally Advanced Gastric Cancer

China
Indiana University
Halyard Health

Completed

Single-shot TAP Block vs Continuous TAP Block (TAP)

Postoperative Pain

United States
Chong Kun Dang Pharmaceutical

Unknown

Efficacy and Safety of TELMINUVO to Stage 2 Hypertension

Hypertension

Korea, Republic of
Taiho Oncology, Inc.

Completed

A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1

Advanced or Metastatic Non-small Cell Lung Cancer

United States, France, Poland, Spain, Italy, Japan
Taiho Oncology, Inc.

Completed

A Trial of TAS-114 in Combination With S-1

Advanced Solid Tumors

France, Belgium, Italy, Switzerland
Soroka University Medical Center

Completed

Sequential Therapy Versus Quadruple Therapy as Second Line Treatment After Failure of the Standard Triple Therapy for H Pylori Infection

Optimization of Second Line Treatment Protocol for H Pylori Eradication

Israel
Ruijin Hospital

Recruiting

Nab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric Cancer

Stage IIIC Gastric Cancer

China
Boston VA Research Institute, Inc.
The University of Texas Health Science Center at San Antonio

Completed

Decreasing Suicide Risk Among Service Members With Posttraumatic Stress

Suicide | Posttraumatic Stress Disorder

United States
Eli Lilly and Company

Completed

A Study of LY2940680 in Healthy Participants

Healthy Participants

United States
Takeda

Completed

Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Participants With Erosive Esophagitis

Erosive Esophagitis

China, Taiwan, Korea, Republic of, Malaysia
Takeda

Completed

Efficacy and Safety of Vonoprazan Compared to Lansoprazole in the Maintenance Treatment of Erosive Esophagitis

Erosive Esophagitis

China, Taiwan, Korea, Republic of, Malaysia
M.D. Anderson Cancer Center
TAP Pharmaceutical Products Inc.

Withdrawn

Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy

Head and Neck Cancer | Gastroesophageal Reflux Disease | Oropharyngeal Cancer
Aga Khan University

Completed

Analgesic Effect of Subcostal TAP Block (UGS-TAP)

Subcostal TAP Block for Multiport Laparoscopic Cholecystectomy
South Australian Health and Medical Research Institute
Flinders University

Completed

Do Iron Supplements Impact the Gut Microbiome of Women of Reproductive Age?

Iron-deficiency | Anemia | Microbial Colonization

Australia
Charite University, Berlin, Germany
International Psychoanalytic University Berlin

Completed

Modified Psychodynamic Psychotherapy for Patients With Schizophrenia (MPP-S)

Schizophrenia | Schizoaffective Disorder

Germany
Saglik Bilimleri Universitesi Gazi Yasargil Training...

Completed

Total Placenta Previa Associated With the Placenta Accreta Spectrum. (PAS)

Maternal; Procedure

Turkey
Changzhou Cancer Hospital of Soochow University

Completed

An Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer (EASE)

Non-small Cell Lung Cancer

China
Taiho Pharmaceutical Co., Ltd.
Yakult Honsha Co., LTD

Completed

Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer (SOLAR)

Gastric Cancer

Japan, Korea, Republic of
Takeda

Completed

A Study to Evaluate the Pharmacokinetics of Dexlansoprazole 30 Milligram (mg) and 60 mg Delayed-release Capsules in Healthy Chinese Participants

Healthy Volunteers

China
Takeda

Completed

Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection

Gastric Ulcer

Taiwan, China, Korea, Republic of, Philippines
Ahn-Gook Pharmaceuticals Co.,Ltd
Korea University Guro Hospital; Dt&Sanomedics

Unknown

Comparing Safety and Efficacy of Amlodipine Verses S Amlodipine in Patients With Essential Hypertension

Essential Hypertension

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients

Acute Gastritis | Chronic Gastritis

Korea, Republic of
Parc de Salut Mar
Instituto de Salud Carlos III

Not yet recruiting

Suicide Prevention and Intervention in Spain: the SURVIVE Study (SURVIVE)

Depression | Suicide, Attempted | Suicide

Spain
Takeda

Completed

A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn

Gastroesophageal Reflux

United States
Chang Gung Memorial Hospital

Recruiting

Dose Escalation and Dose Expansion Study of GAS in Subjects With Metastatic Pancreatic Adenocarcinoma (GAS)

Metastatic Pancreatic Adenocarcinoma

Taiwan
Takeda

Completed

Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection

Duodenal Ulcer

Taiwan, China, Korea, Republic of, Philippines
Takeda

Withdrawn

Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months

Pediatric Gastroesophageal Reflux Disease

United States, Italy, Israel, Mexico, Poland
Yang Jianjun, PhD

Recruiting

Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer

Advanced Gastric Cancer

China
Takeda

Completed

Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents

Gastroesophageal Reflux Disease

United States, Poland, Belgium, Portugal, Italy, Hungary, Mexico, Brazil
Takeda

Completed

Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor Therapy

Gastroesophageal Reflux

United States
Takeda

Completed

Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Maintenance Treatment of Healed Erosive Esophagitis

Erosive Esophagitis

Japan
Takeda

Completed

Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole in Pediatric Subjects With Symptomatic Gastroesophageal Reflux Disease

Gastroesophageal Reflux

United States
Peking University Cancer Hospital & Institute

Recruiting

Paclitaxel (Albumin-bound) Combined With Oxaliplatin and S-1 Conversion Therapy for Gastric Adenocarcinoma

Gastric Adenocarcinoma

China
National Taiwan University Hospital

Withdrawn

The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive Disorder

Depressive Disorder, Major

Taiwan
HK inno.N Corporation

Completed

Triple Therapy With Tegoprazan in H. Pylori Positive Patients

Helicobacter Pylori Infection

Korea, Republic of
Takeda

Completed

Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Erosive Esophagitis

Erosive Esophagitis

Japan
Takeda

Completed

Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal Ulcer

Duodenal Ulcer

Japan
Takeda

Completed

Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn

Gastroesophageal Reflux Disease

United States
Takeda

Completed

Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux Disease

Gastroesophageal Reflux

United States
Millennium Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics of TAK-117 (MLN1117) in Healthy Participants

Neoplasm, Advanced or Metastatic
Takeda

Completed

Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Gastric Ulcer

Gastric Ulcer

Japan
Chong Kun Dang Pharmaceutical

Completed

CKD-828 S-Amlodipine Non-Responder Trial

Hypertension

Korea, Republic of
Takeda

Completed

Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis

Esophagitis, Peptic | Esophagitis, Reflux

United States, Canada, Czech Republic, Lithuania, Slovakia, Latvia, Estonia, Australia
Takeda

Completed

Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease

Gastroesophageal Reflux Disease

United States
Takeda

Completed

Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis

Esophagitis, Peptic | Esophagitis, Reflux

United States, Poland, Bulgaria, India, South Africa, Canada, Peru, New Zealand, Australia, Lithuania, Slovakia, Hungary, Latvia, Germany, Czech Republic

3

Subscribe